KR20240065086A - Gaba a gamma1 pam으로서의 피리도 디아제핀 유도체 - Google Patents
Gaba a gamma1 pam으로서의 피리도 디아제핀 유도체 Download PDFInfo
- Publication number
- KR20240065086A KR20240065086A KR1020247008988A KR20247008988A KR20240065086A KR 20240065086 A KR20240065086 A KR 20240065086A KR 1020247008988 A KR1020247008988 A KR 1020247008988A KR 20247008988 A KR20247008988 A KR 20247008988A KR 20240065086 A KR20240065086 A KR 20240065086A
- Authority
- KR
- South Korea
- Prior art keywords
- chloro
- methyl
- difluorophenyl
- trifluoromethyl
- tetradeca
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21198735 | 2021-09-24 | ||
| EP21198735.9 | 2021-09-24 | ||
| PCT/EP2022/076467 WO2023046877A1 (en) | 2021-09-24 | 2022-09-23 | Pyrido diazepine derivatives as gaba a gamma1 pam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240065086A true KR20240065086A (ko) | 2024-05-14 |
Family
ID=77924305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247008988A Pending KR20240065086A (ko) | 2021-09-24 | 2022-09-23 | Gaba a gamma1 pam으로서의 피리도 디아제핀 유도체 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230109111A1 (enExample) |
| EP (1) | EP4405356A1 (enExample) |
| JP (1) | JP7899312B2 (enExample) |
| KR (1) | KR20240065086A (enExample) |
| CN (1) | CN117957227A (enExample) |
| AR (1) | AR127127A1 (enExample) |
| AU (1) | AU2022351080A1 (enExample) |
| CA (1) | CA3229125A1 (enExample) |
| IL (1) | IL310444A (enExample) |
| TW (1) | TW202322804A (enExample) |
| WO (1) | WO2023046877A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI878507B (zh) | 2020-03-31 | 2025-04-01 | 瑞士商赫孚孟拉羅股份公司 | 作為 GABA A γ1 PAM 的新穎苯并二氮呯衍生物 |
| JP2024537773A (ja) | 2021-09-29 | 2024-10-16 | エフ. ホフマン-ラ ロシュ アーゲー | GABA Aγ1 PAMとしての新規ベンゾジアゼピン誘導体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1185601A (en) * | 1981-02-27 | 1985-04-16 | Walter Hunkeler | Imidazodiazepines |
| WO2003082832A2 (en) * | 2002-03-28 | 2003-10-09 | Wisys Technology Foundation, Inc. | Anxiolytic agents with reduced sedative and ataxic effects |
| JP2012087069A (ja) * | 2010-10-15 | 2012-05-10 | Osaka Prefecture Univ | 1,4−ベンゾジアゼピン誘導体の製造方法および該誘導体 |
-
2022
- 2022-09-22 AR ARP220102559A patent/AR127127A1/es not_active Application Discontinuation
- 2022-09-23 IL IL310444A patent/IL310444A/en unknown
- 2022-09-23 AU AU2022351080A patent/AU2022351080A1/en active Pending
- 2022-09-23 WO PCT/EP2022/076467 patent/WO2023046877A1/en not_active Ceased
- 2022-09-23 EP EP22793720.8A patent/EP4405356A1/en active Pending
- 2022-09-23 KR KR1020247008988A patent/KR20240065086A/ko active Pending
- 2022-09-23 CA CA3229125A patent/CA3229125A1/en active Pending
- 2022-09-23 US US17/934,769 patent/US20230109111A1/en not_active Abandoned
- 2022-09-23 CN CN202280062998.0A patent/CN117957227A/zh active Pending
- 2022-09-23 JP JP2024518302A patent/JP7899312B2/ja active Active
- 2022-09-23 TW TW111136044A patent/TW202322804A/zh unknown
-
2024
- 2024-02-14 US US18/441,558 patent/US20240270744A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023046877A1 (en) | 2023-03-30 |
| EP4405356A1 (en) | 2024-07-31 |
| US20240270744A1 (en) | 2024-08-15 |
| CA3229125A1 (en) | 2023-03-30 |
| TW202322804A (zh) | 2023-06-16 |
| IL310444A (en) | 2024-03-01 |
| JP7899312B2 (ja) | 2026-08-03 |
| CN117957227A (zh) | 2024-04-30 |
| AR127127A1 (es) | 2023-12-20 |
| AU2022351080A1 (en) | 2024-02-15 |
| US20230109111A1 (en) | 2023-04-06 |
| JP2024535343A (ja) | 2024-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4408848B1 (en) | Benzodiazepine derivatives as gaba a gamma1 positive allosteric modulators | |
| US11739095B2 (en) | Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators | |
| US12344614B2 (en) | Benzodiazepine derivatives as GABA a GAMMA1 PAM | |
| US20230141603A1 (en) | Benzodiazepine derivatives as gaba a gamma1 pam | |
| US20240270744A1 (en) | New pyrido diazepine derivatives as gaba a gamma1 pam | |
| US20240287082A1 (en) | New benzodiazepine derivatives as gaba a gamma1 pam | |
| US20240190889A1 (en) | New cyclopenta-thieno-diazepine derivatives as gaba a gamma1 positive allosteric modulators | |
| EP4426705A1 (en) | Cyclohepta-thieno-diazepine derivatives as positive allosteric modulators of the gaba a gamma1 receptor | |
| HK40103189A (en) | Pyrido diazepine derivatives as gaba a gamma1 pam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |